Aashit Shah, MD
Neurology · Roanoke, VANPI 1326085028
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Neurelis, Inc. accounts for 75.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $6,114 and has fallen 97.7% since, to $138 in 2025.
Across 16 payments — averaging $491.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurelis, Inc.$6K
- Natus Medical Incorporated$1K
- Sunovion Pharmaceuticals Inc.$534
- Eisai Inc.$134
- SK Life Science, Inc.$72
- Medtronic$65
- plus $104 from 2 others
Across 13 payments — averaging $7228.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eisai Inc.$73K
- SK Life Science, Inc.$21K
What the payments were for
- Consulting fees$4,55458%
- Speaking & faculty fees$1,53420%
- Travel & lodging$1,17815%
- Food & beverage$5938%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurelis, Inc. | 8 | $5,950 |
| Natus Medical Incorporated | 1 | $1,000 |
| Sunovion Pharmaceuticals Inc. | 1 | $534 |
| Eisai Inc. | 2 | $134 |
| SK Life Science, Inc. | 1 | $72 |
| Medtronic | 1 | $65 |
| Neuropace, Inc. | 1 | $57 |
| Livanova USA, Inc. | 1 | $46 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,860 in reported general payments places this provider in the 75th percentile of 474 neurology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 13 | $120,837 |
| XcopriCenobamate | 38 | $41,604 |
| Lacosamide | 134 | $23,274 |
| DilantinPhenytoin Sodium Extended | 15 | $8,226 |
| Levetiracetam | 261 | $7,482 |
| Carbamazepine ErCarbamazepine | 46 | $4,925 |
| Clobazam | 42 | $3,328 |
| Divalproex Sodium | 53 | $2,686 |
| Oxcarbazepine | 41 | $2,677 |
| Lamotrigine | 67 | $1,635 |
| Divalproex Sodium ErDivalproex Sodium | 22 | $1,605 |
| Zonisamide | 26 | $1,362 |
| Phenytoin | 27 | $1,292 |
| Phenobarbital | 48 | $1,063 |
| Topiramate | 56 | $1,037 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| SK Life Science, Inc.Xcopri | $72 | $41,60438 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 474 neurology providers in Virginia.
Other neurology in Roanoke
- Soundarya Nagaraja GowdaRoanoke$38K
- Ramsey FalconerAlexandria$2M
- Robert ShinCharlottesville$1.7M
- Heidi CraytonVienna$1.5M
- Mark LandrioWinchester$631K
- Catherine HamRichmond$603K
- Jill CramerChristiansburg$598K
- Rahul DaveFairfax$540K
- Daniel HardyRichmond$382K
- Ingrid Loma MillerNorfolk$364K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.